Nexalin Technology (NXL) Competitors $1.62 -0.11 (-6.36%) As of 01:08 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXL vs. FONR, NSPR, SRTS, MLSS, ZYXI, CTSO, ICCM, VANI, INO, and NTRBShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include FONAR (FONR), InspireMD (NSPR), Sensus Healthcare (SRTS), Milestone Scientific (MLSS), Zynex (ZYXI), Cytosorbents (CTSO), IceCure Medical (ICCM), Vivani Medical (VANI), Inovio Pharmaceuticals (INO), and Nutriband (NTRB). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. FONAR InspireMD Sensus Healthcare Milestone Scientific Zynex Cytosorbents IceCure Medical Vivani Medical Inovio Pharmaceuticals Nutriband FONAR (NASDAQ:FONR) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Does the media favor FONR or NXL? In the previous week, FONAR and FONAR both had 2 articles in the media. Nexalin Technology's average media sentiment score of 0.94 beat FONAR's score of 0.44 indicating that Nexalin Technology is being referred to more favorably in the news media. Company Overall Sentiment FONAR Neutral Nexalin Technology Positive Does the MarketBeat Community believe in FONR or NXL? FONAR received 178 more outperform votes than Nexalin Technology when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 66.67% of users gave Nexalin Technology an outperform vote. CompanyUnderperformOutperformFONAROutperform Votes18074.69% Underperform Votes6125.31% Nexalin TechnologyOutperform Votes266.67% Underperform Votes133.33% Which has higher valuation & earnings, FONR or NXL? FONAR has higher revenue and earnings than Nexalin Technology. Nexalin Technology is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFONAR$101.57M0.74$10.57M$1.1510.56Nexalin Technology$168.72K136.41-$4.65M-$0.82-2.11 Is FONR or NXL more profitable? FONAR has a net margin of 7.68% compared to Nexalin Technology's net margin of -3,407.98%. FONAR's return on equity of 4.94% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets FONAR7.68% 4.94% 3.70% Nexalin Technology -3,407.98%-187.59%-167.21% Which has more risk and volatility, FONR or NXL? FONAR has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 4.6, suggesting that its stock price is 360% more volatile than the S&P 500. Do institutionals and insiders hold more shares of FONR or NXL? 50.6% of FONAR shares are owned by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are owned by institutional investors. 2.2% of FONAR shares are owned by insiders. Comparatively, 24.0% of Nexalin Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate FONR or NXL? Nexalin Technology has a consensus price target of $5.00, indicating a potential upside of 189.02%. Given Nexalin Technology's stronger consensus rating and higher possible upside, analysts plainly believe Nexalin Technology is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryFONAR beats Nexalin Technology on 10 of the 17 factors compared between the two stocks. Remove Ads Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyElectromedical equipment IndustryBusiness SectorNASDAQ ExchangeMarket Cap$23.68M$3.14B$7.02B$7.57BDividend YieldN/A1.80%2.70%4.32%P/E Ratio-2.7014.3429.7317.82Price / Sales136.4143.73154.9794.61Price / CashN/A44.0931.6134.64Price / Book4.023.334.564.00Net Income-$4.65M$94.03M$195.82M$247.23M7 Day Performance-2.26%-2.35%-0.27%1.44%1 Month Performance-19.53%-8.47%-6.20%-6.26%1 Year Performance16.89%-21.21%4.18%0.59% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology3.1616 of 5 stars$1.62-6.4%$5.00+208.6%-12.6%$21.55M$168,721.00-2.533Gap DownFONRFONAR1.3102 of 5 stars$13.00-2.8%N/A-27.9%$80.64M$101.57M11.30480Short Interest ↑Positive NewsNSPRInspireMD2.0215 of 5 stars$2.59-1.9%$4.75+83.4%+8.4%$76.90M$7.01M-3.4550Gap UpSRTSSensus Healthcare2.4868 of 5 stars$4.48+0.4%$13.00+190.2%+45.3%$73.90M$41.81M11.2040Gap DownMLSSMilestone Scientific1.618 of 5 stars$0.89+2.3%$1.25+40.4%+65.5%$69.32M$8.88M-12.7130Analyst ForecastNews CoverageZYXIZynex3.0017 of 5 stars$2.16flat$10.25+374.5%-81.6%$65.29M$192.35M14.40770Analyst ForecastGap DownHigh Trading VolumeCTSOCytosorbents2.1203 of 5 stars$0.99+2.1%$4.67+371.1%+16.5%$61.91M$35.59M-2.75220ICCMIceCure Medical2.4273 of 5 stars$1.11-2.6%$2.50+125.2%-17.0%$61.61M$3.29M-3.8360Gap DownVANIVivani Medical2.8378 of 5 stars$1.02+6.3%$4.00+292.2%-49.0%$60.42MN/A-2.2720Analyst ForecastShort Interest ↑News CoverageGap UpINOInovio Pharmaceuticals3.42 of 5 stars$1.58+1.3%$12.20+672.2%-84.0%$57.93M$217,756.00-0.40320Short Interest ↑High Trading VolumeNTRBNutriband2.9058 of 5 stars$5.09-5.7%$13.00+155.4%+25.6%$56.53M$2.02M-7.1710 Remove Ads Related Companies and Tools Related Companies FONAR Alternatives InspireMD Alternatives Sensus Healthcare Alternatives Milestone Scientific Alternatives Zynex Alternatives Cytosorbents Alternatives IceCure Medical Alternatives Vivani Medical Alternatives Inovio Pharmaceuticals Alternatives Nutriband Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NXL Stock Free NXL Stock Alerts